Navigation Links
ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis
Date:2/23/2009

5-50 info@bioinvent.com http://www.bioinvent.com For further information, please contact: ThromboGenics NV Patrik De Haes MD Chief Executive Officer Tel : +32(0)16-75-13-10 E-mail: patrik.dehaes@thrombogenics.com: Andy De Deene MD Clinical Director Europe Tel: +32(0)16-75-13-10 E-mail andy.dedeene@thrombogenics.com Citigate Dewe Rogerson Amber Bielecka, David Dible, Nina Enegren Tel: +44(0)207-638-95-71 E-mail: amber.bielecka@citigatedr.co.uk BioInvent International AB Svein Mathisen President & CEO Tel: +46(0)46-286-85-67 Mobile: +46(0)708-97-82-13 E-mail: svein.mathisen@bioinvent.com Cristina Glad Executive Vice President Tel: +46(0)46-286-85-51 Mobile: +46(0)708-16-85-70 E-mail: cristina.glad@bioinvent.com College Hill (media enquiries) Holly Griffiths, Sue Charles, John McIntyre Tel: +44(0)20-7457-2020 E-mail: bioinvent@collegehill.com
'/>"/>
SOURCE ThromboGenics NV
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. ThromboGenics N.V.: Business Update
2. ThromboGenics Announces Half Year Results 2008
3. ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
4. ThromboGenics Announces Private Investors Acquire 8% Stake in the Company
5. ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody
6. ThromboGenics N.V. - Business Update
7. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
8. ThromboGenics Announces 2007 Full Year Results
9. ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer
10. ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting
11. ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)...   Sigma-Aldrich Corporation (Nasdaq: ... a new gene editing partnership with the University ... the partnership, Sigma-Aldrich will provide the Vector Core ... dedicated gene editing bioinformaticians. The partnership ... the U-M Medical School. One initiative already underway, ...
(Date:9/18/2014)... 18, 2014 SeqLL Inc., the ... technology, announced today the closing of a $1M ... by Genomic Diagnostic Technologies, will increase the power ... , Founded in March 2013 by Daniel Jones, ... at Helicos BioSciences, SeqLL has continued to offer ...
(Date:9/18/2014)... be pretty expensive. Now a team led by an ... library of designs that will let scientists slash the ... syringe pump. , Syringe pumps are used to dispatch ... mixing chemicals in a reaction. They can also cost ... and his team of Michigan Tech students published the ...
(Date:9/18/2014)... USC have developed a new microscopy technology that ... animals at higher-than-ever resolution. , Dubbed "Complementation Activated ... resolutions that are an order of magnitude finer ... the behavior of biomolecules at the nanometer scale. ... by Nature Communications , the researchers behind ...
Breaking Biology Technology:Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership 2Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership 3Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership 4SeqLL Closes Series-A Funding Round for Expansion of Single Molecule Sequencing 2Doing science just got cheaper -- and faster 2Scientists pioneer microscopy technique that yields fresh data on muscular dystrophy 2
... 18 Volcano Corporation,(Nasdaq: VOLC ), ... measurement (FM) products designed to enhance the ... disease, announced today that it,has completed its ... CardioSpectra is a privately-held company developing innovative ...
... Dec. 18 Pharmos Corporation,(Nasdaq: PARS ) ... has elected,to resign from the Company., Mr. ... instrumental in the,strategic acquisition and the subsequent integration ... Vela acquisition,Mr. Rubino has been focused on key ...
... Vice President and General Manager of facility ... prescriptions a week, FRANKLIN LAKES, N.J., Dec. 18 ... nation,s leading pharmacy benefit,managers, today announced that AllPoints at Anson ... most-advanced automated pharmacy,capping a nearly year-long search that spanned 48 ...
Cached Biology Technology:Volcano Announces Closing of CardioSpectra Acquisition 2Volcano Announces Closing of CardioSpectra Acquisition 3Pharmos Corporation Announces President & COO Alan L. Rubino to Leave Company 2Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the World's Largest, Most-Advanced Automated Pharmacy 2Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the World's Largest, Most-Advanced Automated Pharmacy 3Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the World's Largest, Most-Advanced Automated Pharmacy 4Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the World's Largest, Most-Advanced Automated Pharmacy 5
(Date:9/17/2014)... four-year project, delivering its first release in 2004. After ... several EC projects, as a part of the EC-FP7 ... to increase the general awareness of the work done ... of the Fauna Europaea results, the Biodiversity ... tools to prepare data papers for all 56 major ...
(Date:9/17/2014)... Biomedical Informatics at IMIM (Hospital del Mar Medical Research ... have recently published a study in eLife ... role in the evolution of new proteins, some of ... discovered., Ribosomes produce proteins from the instructions found in ... genome is RNA containing information for the synthesis of ...
(Date:9/17/2014)... of researchers working on a Carnegie expedition in Australia,s ... have plummeted 40% since the mid-1970s. The scientists suggest ... in this perilous slowdown. , In a quest ... the team compared current measurements of the growth rate ... similar measurements taken more than 30 years ago. Their ...
Breaking Biology News(10 mins):Contributions on Fauna Europaea: Data papers as innovative model on expert involvement 2Parts of genome without a known function may play a key role in the birth of new proteins 2Coral growth rate plummets in 30-year comparison 2
... collaboration with scientists at the University of California, San Diego ... switch that plays a crucial role in the development of ... issue of the journal Molecular Cell, provide a template for ... a protein called Scp1, at will. , "Scp1 is an ...
... the reach of a novel genome mapping method ... and more cost-effective tool than traditional DNA sequencing. ... Michael Waterman, USC University Professor in molecular and ... the massive amounts of data created by a ...
... 2005, 40.3 million people in the world, including 25.8 million ... the origin of HIV-1, responsible for the AIDS pandemic, has ... months ago, the team of Martine Peeters, director of research ... unit UMR 145 jointly involving the IRD and the University ...
Cached Biology News:Detailed 3-D image catches a key regulator of neural stem cell differentiation in action 2Detailed 3-D image catches a key regulator of neural stem cell differentiation in action 3Powerful genome ID method extended to humans 2Wild gorillas carriers of a SIV virus close to the AIDS virus 2
... This DuoSet ELISA Development kit contains the ... sandwich ELISAs to measure natural and recombinant ... serum. Each kit contains sufficient materials ... plates, provided that the following conditions are ...
RABBIT ANTI PORCINE CARBOXYPEPTIDASE B...
Recombinant Ovine (Sheep) Growth Hormone, Ultra Pure...
Request Info...
Biology Products: